Strata Critical Medical (SRTA) Change in Accured Expenses (2019 - 2026)

Strata Critical Medical has disclosed Change in Accured Expenses across 8 years of filings, most recently posting -$2.2 million for Q1 2026.

• In Q1 2026, Change in Accured Expenses rose 5.27% year-over-year to -$2.2 million; the TTM figure through Mar 2026 stood at $2.5 million (up 759.1% YoY), while the FY2025 annual figure was $2.4 million, up 128.52% from the prior year.
• Change in Accured Expenses slipped to -$2.2 million in Q1 2026, from $795000.0 in the prior quarter.
• Over the last five years, Change in Accured Expenses for SRTA reached as high as $5.0 million in Q4 2023 and fell as low as -$10.2 million in Q1 2024.
• The 5-year median for Change in Accured Expenses is $795000.0 (2025), against an average of $322800.0.
• Annual changes were most pronounced in 2023 — Change in Accured Expenses slumped 228.34% — and 2025, when it jumped 39850.0%.
• A 5-year view of Change in Accured Expenses shows it stood at $1.3 million in 2022, then jumped by 289.25% to $5.0 million in 2023, then slumped by 100.04% to -$2000.0 in 2024, then jumped by 39850.0% to $795000.0 in 2025, then sank by 371.45% to -$2.2 million in 2026.
• According to Business Quant data, Change in Accured Expenses over the past three periods registered -$2.2 million, $795000.0, and $669000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.